NASDAQ · AHPA
Financial Services · Shell Companies
$6.13
Down-$0.72 (-10.45%)
Updated Aug 15, 2026, 6:59 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
AHPA does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning AHPA.
AHPA research
Company profile and research snapshot.
Avista Public Acquisition Corp. II does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. The company focuses on pursuing businesses in the healthcare industry. Avista Public Acquisition Corp. II was incorporated in 2021 and is based in New York, New York.
Consensus and target data currently published for this company.
No generated briefing is available yet.
Zacks Investment Research · May 5, 2022
Ligand (LGND) reports encouraging first-quarter 2022 numbers by beating estimates on both counts. However, Captisol sales get hurt by lower demand for COVID-19 therapies.
Zacks Investment Research · Mar 24, 2022
Ligand (LGND) is on track to spin-off its OmniAb business in the second half of 2022. It signs a merger agreement with a special purpose acquisition company (SPAC), Avista Public Acquisition Corp. for the same.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AHPA.
No results
No recent SID articles mention AHPA.
